Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

11.94
Delayed Data
As of Feb 05
 +0.25 / +2.14%
Today’s Change
9.16
Today|||52-Week Range
17.55
-29.14%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close11.69
Today’s open11.55
Day’s range10.70 - 12.03
Volume6,493,538
Average volume (3 months)1,723,983
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-41.53%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book43.12

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co-0.61-1.40%
INCRINC Research Holding...-1.89-4.88%
DBVTDBV Technologies SA-2.08-7.90%
NXTMNxStage Medical Inc-1.16-6.05%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 24, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers